Join us at the Alzheimer’s disease/Parkinson’s disease conference in Torino where Bioclinica Research is pleased to be attending and speaking.
This exciting event is a new joint meeting between the International Geneva/Springfield Symposium on Advances in Alzheimer Therapy (AAT) and AD/PD. It is where to connect with others in the field and share about the latest breakthroughs in treatment, translational R&D, early diagnosis, drug development and clinical trials in Alzheimer’s, Parkinson’s and other related neurological disorders. We invite you to participate in an informative session exploring ways to increase patient engagement and participation in Alzheimer’s disease clinical trials to be led by our own Marieke Cajal, Ph.D., Research Development Director, Bioclinica Research. Session details below.
Part of the "Care of AD Patients and Lifestyle” symposium beginning at 11 am in Sala Londra
Date and Time: March 18, 12:20 pm
Speaker: Marieke Cajal, Ph.D.
As part of this symposium, Dr. Cajal will discuss some of the greatest obstacles that stand in the way of patient engagement and participation in Alzheimer’s disease clinical trials and how to overcome them. She will provide real-life success stories drawn from her extensive work with this special patient population. As part of her talk, Dr. Cajal will share findings of the use of memory testing and APOE genetic testing in combination with patient and family counseling to increase engagement and participation in AD trials.